retatrutide phase 2 trial results weight loss π¨Breaking: Retatrutide's first 3 T2D data just dropped. βΈ A1C: β2.0% at 40 weeks βΈ Weight: β36.6 lbs (β16.8%) at 12 mg βΈ No plateau β curve still descending Mazdutide vs retatrutide: dual agonist
Description
Prefilled pens like Ozempic, Wegovy, Mounjaro, and Zepbound are designed for convenience and require minimal preparation
GLP-1 mimetics show promise due to their anti-inflammatory, neuroprotective, and neurotrophic properties
However, this response may be less potent than in individuals without diabetes
01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
The practical implication is that poor early response is uncommon and doesnt necessarily predict poor ultimate outcomes
